Cresco Labs (CRLBF) Non Operating Income (2020 - 2026)
Cresco Labs (CRLBF) posted Non Operating Income of -$14.0 million for Q1 2026, down 20.41% on a QoQ basis from -$11.6 million in Q4 2025, and up 3.72% year-over-year from -$13.5 million in Q1 2025.
Cresco Labs (CRLBF) Non Operating Income (2020 - 2026) Analysis & Trends
Cresco Labs' Non Operating Income history runs 7 years deep, the most recent figure standing at -$14.0 million for Q1 2026.
- Quarterly Non Operating Income rose 3.72% year-over-year to -$14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.9 million (up 43.88% YoY) and the FY2025 annual result came in at -$67.4 million, up 42.81% from the prior year.
- Non Operating Income was -$14.0 million for Q1 2026 at Cresco Labs, down from -$11.6 million in the prior quarter.
- Across five years, Non Operating Income topped out at -$757000.0 in Q3 2022 and bottomed at -$73.3 million in Q2 2024.
- A 5-year average of -$17.7 million and a median of -$14.3 million in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 91.95% — and 2023, when it slumped 1410.57%.
- Cresco Labs' Non Operating Income stood at -$13.4 million in 2022, then fell by 6.71% to -$14.3 million in 2023, then declined by 14.49% to -$16.4 million in 2024, then advanced by 29.06% to -$11.6 million in 2025, then decreased by 20.41% to -$14.0 million in 2026.
- Business Quant data shows CRLBF's Non Operating Income at -$14.0 million in Q1 2026, -$11.6 million in Q4 2025, and -$27.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | -13.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.97 Mn |
| Dec 31, 2025 | -11.60 Mn |
| Sep 30, 2025 | -27.93 Mn |
| Jun 30, 2025 | -13.40 Mn |
| Mar 31, 2025 | -14.51 Mn |
| Dec 31, 2024 | -16.35 Mn |
| Sep 30, 2024 | -15.02 Mn |
| Jun 30, 2024 | -73.32 Mn |
| Mar 31, 2024 | -13.22 Mn |
| Dec 31, 2023 | -14.28 Mn |
| Sep 30, 2023 | -11.44 Mn |
| Jun 30, 2023 | -18.77 Mn |
| Mar 31, 2023 | -14.59 Mn |
| Dec 31, 2022 | -13.38 Mn |
| Sep 30, 2022 | -757,000.00 |
| Jun 30, 2022 | -7.34 Mn |
| Mar 31, 2022 | -21.14 Mn |
| Dec 31, 2021 | -3.94 Mn |
| Sep 30, 2021 | -9.41 Mn |
| Jun 30, 2021 | 1.24 Mn |